Reviewed by the Help Dementia Editorial Team — our editors review every article for accuracy against guidance from the National Institute on Aging, the Alzheimer’s Association, and peer-reviewed sources.
Concerning screening sits at the center of this dementia and brain health question.
A concerning screening result for cognitive decline or dementia isn’t a diagnosis—it’s a signal to take specific action. Your first steps should be to schedule a comprehensive evaluation with a neurologist or cognitive specialist, gather your complete medical records, and bring a trusted family member to your appointments. If you received your result from a brief screening tool at a doctor’s office or online, understand that these are designed to identify people who may need further testing, not to confirm disease. For example, someone who scores low on the Montreal Cognitive Assessment (MoCA) because they’re stressed about a family crisis or haven’t slept well may improve significantly once those temporary factors resolve.
A concerning result can feel frightening, but it’s also an opportunity. Early evaluation and diagnosis—if cognitive impairment is actually present—opens doors to treatment, planning, and support that can make a real difference in how the condition progresses. The distinction between normal aging, mild cognitive impairment, and dementia is not something a single screening test can determine. That requires a detailed neuropsychological evaluation, medical imaging, blood work, and a careful history.
Table of Contents
- How to Interpret Your Screening Result Accurately
- Scheduling a Comprehensive Neuropsychological Evaluation
- When to Involve Family and What to Tell Them
- Creating an Action Plan and Medical Documentation
- Understanding the Risk of False Positives and When Not to Panic
- The Role of Lifestyle and When to Modify It
- Planning for Follow-Up and Adapting Your Approach
- Conclusion
- Frequently Asked Questions
How to Interpret Your Screening Result Accurately
cognitive screening tools are designed to be sensitive, meaning they catch people who might have problems—but they also catch many people who don’t. They’re meant to trigger further investigation, not to deliver a final verdict. Tools like the Montreal Cognitive Assessment, the Mini Cog, or the Cognivue screening take 5 to 15 minutes and can be influenced by education level, language, mood, fatigue, medication side effects, or even anxiety about the test itself. A person with high education may score lower than their actual cognitive ability if they’re tired, while someone with less formal schooling might score even lower on the same test despite having normal cognition for their age.
The positive predictive value of screening tests varies widely depending on which test you took and who administered it. A result that’s concerning at age 55 may have different implications at age 85, when some cognitive slowing is expected. Your doctor should tell you exactly what your score means in context—not just whether it’s “high” or “low.” If they didn’t explain this clearly, ask. Write down the specific score, the name of the test, and the date, and request a copy of the result.
Scheduling a Comprehensive Neuropsychological Evaluation
After a concerning screening, the next critical step is a full evaluation. This is different from a screening and typically takes several hours. A neuropsychologist or cognitive neurologist will test your memory, attention, language, visuospatial skills, and executive function in detail.
They’ll also take a thorough history: when did family members first notice changes, how has work performance been, are there medical problems that could affect the brain like uncontrolled diabetes or heart disease, what medications are you on, and has there been a recent head injury or illness? A limitation of comprehensive testing is that it requires access to specialists, which many people don’t have in their communities. If you live in a rural area or don’t have insurance that covers neuropsychology, a geriatrician or neurologist may conduct a less detailed but still useful cognitive evaluation. Brain imaging (MRI or CT scan) is often ordered to rule out strokes, tumors, or normal pressure hydrocephalus—conditions that cause cognitive symptoms but may be treatable. Blood tests to check for vitamin B12 deficiency, thyroid problems, and increasingly, blood biomarkers for Alzheimer’s disease (like phosphorylated tau or amyloid) are standard parts of the workup.
When to Involve Family and What to Tell Them
Your evaluation and results are private, but you’ll need emotional and logistical support from people you trust. Bring a family member to at least one appointment—ideally someone who sees you regularly and has noticed whether your memory or thinking has changed. doctors benefit from a collateral history; a spouse or adult child can describe changes the person themselves may minimize or not notice. You don’t need to tell everyone about a concerning result, but choosing one or two trusted people to know allows them to support you without becoming a source of anxiety.
Some families struggle with how much information to share with aging parents or with each other. A specific example: an adult daughter notices her mother’s doctor mentioned a concerning MoCA score during a routine visit. The daughter should ask her mother whether she wants to discuss this further and whether she’d like the daughter to be involved in follow-up appointments. Some people prefer to wait for a full evaluation before telling other family members; others want family support from the beginning. There’s no single right answer, but open, honest communication usually works better than surprise or secrecy.
Creating an Action Plan and Medical Documentation
Once you have results from a comprehensive evaluation, you’ll have clearer information about whether you have normal aging, mild cognitive impairment, or a dementia diagnosis. Write this down and keep it organized. Create a folder (digital or paper) with: your test results, the neurologist’s report, lists of your medications, previous brain imaging, and any relevant medical history. Make copies for your records and for any new doctors who need them.
If your evaluation shows changes that warrant treatment, discuss options with your neurologist. For Alzheimer’s disease, medications like lecanemab or donepezil may be recommended depending on your stage of disease and other health factors. The tradeoff with any medication is potential benefits (slowing cognitive decline, at least temporarily) versus side effects and cost. For mild cognitive impairment, which doesn’t always progress to dementia, the approach may be different—focusing on managing blood pressure, staying cognitively and physically active, and monitoring for change rather than starting medications. Document your doctor’s recommendations and your own preferences about future care; if you’re worried about a condition progressing, knowing your own values (what trade-offs you’re willing to accept) matters as much as any medication.
Understanding the Risk of False Positives and When Not to Panic
Between 10 and 20 percent of people with mild cognitive impairment don’t progress to dementia over ten years; some actually improve. A single concerning screening result, especially from a brief test, is not a diagnosis. People find out their cognitive abilities are stable when they return for follow-up testing months or a year later. Temporary medical conditions—sleep apnea, depression, medication side effects, urinary tract infections, diabetes that’s not well controlled—can produce symptoms that look like dementia but are reversible. Before concluding you have a progressive neurological disease, make sure your doctor has ruled these out.
A warning: the anxiety produced by a concerning result can actually make cognition feel worse temporarily. Stress, sleep disruption, and worry can impair memory and attention in anyone. This is real, but it’s not the same as progressive cognitive disease. If you received a concerning result weeks or months ago and were referred for further evaluation, that evaluation is the test that matters—not the initial screening. If you’re still waiting for an appointment and feeling very anxious, talking to your primary care doctor or a mental health professional might help while you wait.
The Role of Lifestyle and When to Modify It
Regardless of what your evaluation shows, there are changes proven to support brain health: regular aerobic exercise, adequate sleep, a Mediterranean-style diet, cognitive engagement, strong social connections, and management of cardiovascular risk factors. If your concerning result has prompted you to make these changes, that’s beneficial. But understand that lifestyle modifications are not a cure for dementia if a disease process is already underway. They may slow progression or improve quality of life, but they won’t reverse a diagnosis of Alzheimer’s disease or other dementias.
An example: a 68-year-old receives a concerning MoCA score, gets a full evaluation confirming mild cognitive impairment, and then starts exercising five times a week, joins a book club, and overhauls their diet. These are all worthwhile. Some of these changes might slow progression; they will definitely improve general health and mood. But if the underlying issue is Alzheimer’s pathology, exercise and diet alone won’t stop it. The lifestyle changes work best when combined with appropriate medical treatment and monitoring.
Planning for Follow-Up and Adapting Your Approach
A concerning screening result should lead to a definite plan for follow-up. If you had normal cognition, when will you be retested? If you have mild cognitive impairment, how often will your doctor evaluate you—every six months, yearly? If you have dementia, what’s the monitoring schedule? Cognitive changes don’t follow a straight line. Some people plateau for years, others decline more quickly. Regular follow-up helps your doctor adjust your care plan and catch new medical problems that might affect your brain.
Technology and research are changing how we approach cognitive decline. Newer blood tests for Alzheimer’s pathology are becoming standard, and they may help identify people at risk even before symptoms appear. Some people now know they have Alzheimer’s pathology in their brain from a blood test alone—they have no symptoms yet. This opens questions about whether to treat and how to plan for the future. These are emerging areas; your neurologist can discuss what’s known and what’s still uncertain.
Conclusion
A concerning cognitive screening result is a prompt to seek comprehensive evaluation, not a diagnosis in itself. Take the result seriously enough to schedule follow-up testing with a cognitive specialist, but don’t assume it means you have dementia. Bring medical records, involve a trusted family member, and ask your doctors to explain exactly what your results mean for you. The next steps—a full neuropsychological evaluation, medical imaging, blood work, and careful medical history—are what actually determine whether you have normal aging, mild cognitive impairment, or dementia, and what should be done about it.
Use this opportunity to understand your own brain health and to clarify your medical values. If cognitive impairment is confirmed, knowing this early allows you to make informed decisions about treatment, planning, and support. If the full evaluation shows normal cognition or reversible causes of your symptoms, you’ll have the reassurance and information you need. Either way, the path forward starts with a thorough evaluation and clear communication with your healthcare team.
Frequently Asked Questions
Does a low screening score mean I definitely have dementia?
No. Screening tests are designed to be sensitive (catch people who might have problems), which means they also catch many people without actual cognitive disease. A single low score needs to be interpreted in context—your age, education, language, emotional state, and medications all matter. Only a comprehensive evaluation can determine whether you truly have cognitive impairment or dementia.
How long does a neuropsychological evaluation take?
A full neuropsychological evaluation typically takes three to eight hours, sometimes spread over two or more sessions. The actual testing is usually three to five hours, plus time for history-taking and explanation of results. Some offices do shorter evaluations if that’s all your insurance covers; ask what’s included.
If I have a concerning result, should I tell my employer or family immediately?
Not necessarily. It depends on your situation. If you don’t yet have a diagnosis, telling many people may cause unnecessary alarm. Consider waiting for results from a comprehensive evaluation. If you do have a confirmed diagnosis and it may affect your work, discussing accommodations with a manager or HR representative may be necessary, but that’s usually a conversation for after the diagnosis is clear.
Can medication reverse a concerning screening result?
Medications like lecanemab or donepezil may slow cognitive decline in early Alzheimer’s disease, but they don’t reverse it. If your concerning result comes from a reversible cause—like low B12, thyroid problems, depression, or sleep apnea—treating that underlying problem may improve your cognition significantly. Your doctor will help determine whether your condition is likely reversible.
What should I do while waiting for my comprehensive evaluation appointment?
Maintain your usual routines, prioritize sleep and exercise, manage stress, and document any cognitive changes you notice. Write down specific examples of memory or thinking problems, when they happen, and whether they’re getting worse or staying stable. This information helps your neurologist understand your pattern of change. Avoid excessive internet searching about dementia, which can increase anxiety without providing clarity.
How often should I get retested after a concerning screening?
That depends on your initial results and evaluation. If you’re normal, screening every 1 to 3 years might be appropriate depending on your age and risk factors. If you have mild cognitive impairment, your doctor may recommend follow-up every 6 to 12 months. If you have dementia, you may be monitored every 3 to 6 months. Ask your neurologist for a specific schedule.
You Might Also Like
- Why Screening Should Lead to Real Follow-Up
- Why Scientific Headlines Should Be Translated Into Practical Advice
- Why Families Should Ask About Benefits and Risks
For more, see NIH MedlinePlus — dementia.
